GLP-1 Weight Regain: What to Expect and How to Plan

Nov 4

9 min read

Most people who stop a GLP-1 medication regain some of the weight they lost, and the largest share returns within the first year. Regain is not inevitable in full, though. Large datasets show that many people keep part of their loss, and the choices you make before, during and after stopping change the picture. This guide covers what the research shows, why the weight comes back, and how to build a plan with your clinician.

TL;DR

A 2026 BMJ meta-analysis found an average regain of about 0.4 kg (roughly 0.9 lb) per month after stopping weight-management medication.
One year after stopping a GLP-1, people had regained about 60% of the weight they lost, according to a 2026 meta-regression.
Regain is not all-or-nothing: in a large real-world U.S. analysis, roughly half of patients still held on to some of their loss two years later.
A gradual taper, protein, strength training, sleep and follow-up care are the levers most worth discussing with your clinician.
The best time to plan for life after a GLP-1 is before you stop, not after the scale moves.

How much weight comes back after stopping a GLP-1?
Does everyone regain it all?
Why the weight comes back
What to discuss with your clinician before you stop
The habits that protect your progress
When a GLP-1 alone is not the whole plan
Perspective
How Green Circle Wellness can support the transition
FAQ
Sources

How much weight comes back after stopping a GLP-1?

The short answer: on average, a lot of it, and at a steady pace. A 2026 systematic review and meta-analysis in The BMJ pooled 37 studies, 63 treatment arms and 9,341 participants. After people stopped weight-management medication, they regained an average of 0.4 kg per month, and the projection pointed to a return to baseline weight within about 1.7 years.

A second analysis in eClinicalMedicine looked specifically at GLP-1 receptor agonists. It estimated that participants had regained 60% of the weight lost during treatment by one year after stopping. The model projected regain levelling off at about 75.3% of the original loss, which means roughly a quarter of the treatment-associated loss could remain.

The STEP 1 trial extension points the same way. People who stopped semaglutide 2.4 mg and the accompanying lifestyle program regained about two-thirds of their prior weight loss one year after withdrawal.

Regain by medication

A 2026 systematic review of post-cessation weight regain reported pooled regain of 7.20% of body weight within about a year across drug classes and study designs. Its subgroup figures differ by medication:

Medication stopped	Average regain (% of body weight)
Liraglutide (3.0 mg)	4.83%
Semaglutide (2.4 mg)	7.19%
Tirzepatide	13.04%

These are averages across studies with different designs, treatment lengths and follow-up. They tell you the direction and rough size of the effect, not what will happen to you. Tirzepatide users often lose more on treatment, so there is more to regain, which is one reason the raw figure is larger.

Does everyone regain it all?

No. The trial-based numbers describe averages, and real-world data show a wider spread. A 2025 Epic Research analysis of 188,722 patients in electronic health records, all of whom had used a GLP-1 for at least 90 days and lost at least 5 pounds, looked at outcomes 24 months after stopping:

Complete regain: 23% of semaglutide users, 21% of tirzepatide users and 27% of liraglutide users.
Maintained their loss or lost more: 56.1% of semaglutide users, 55.2% of tirzepatide users and 51.9% of liraglutide users.

The analysis also noted that weight trajectories generally stabilized after 12 months, with only minor shifts through year two. That matches the plateau the meta-regression predicts.

This is observational data from health records, and the people who stop in the real world are not a random group. Some stopped because they reached a goal, some because of side effects, some because of cost or supply. Still, it answers a common fear: one person in four or five regains everything, but the majority keep at least something.

Why the weight comes back

GLP-1 medications work largely by reducing appetite and slowing the pace at which you feel hungry again. When the drug leaves your system, that effect fades. A 2026 review of early regain after discontinuation describes the most likely explanation as the abrupt removal of pharmacological appetite suppression while the body is still adapted to a lower weight. That adaptation includes higher signaling from hunger hormones such as ghrelin and reduced energy expenditure. The authors note that evidence for some proposed mechanisms, such as changes in GLP-1 receptor signaling, remains limited.

In plain terms: your body treats a lower weight as something to correct. The medication was quieting that drive. Without it, hunger returns, often at once, and the habits that were easy to follow on treatment get harder.

Factors that shape how much you regain

The research does not give one formula, but several factors recur in the literature and in clinical practice:

How you stop. Stopping abruptly can bring a sudden jump in appetite. A staged reduction gives you time to adjust your eating and routines.
What you built while on treatment. Protein intake, strength training, sleep and meal structure are the habits that carry over. The STEP 1 participants stopped both the drug and the lifestyle program, and regained about two-thirds.
How much you lost. A larger loss leaves more to regain, and your body has more to defend.
The medication itself. As the table above shows, average regain differs by drug.
Why you stopped. Stopping because of side effects, cost, supply or a planned end point each calls for a different plan.
Whether treatment addressed underlying drivers. Hormones, gut health, sleep, stress and nutrient status can all influence appetite and metabolism.

What to discuss with your clinician before you stop

The BMJ review cautions against using weight-management medication short term without a broader approach, and says prolonged treatment may be needed to sustain the health benefits. So the first conversation is not only how to stop, but whether, when and with what support. For some people the right answer is staying on a lower maintenance dose. For others it is a planned step-down.

Harvard Health suggests asking your doctor about tapering gradually, taking a lower dose or using the medication intermittently. An American Academy of Family Physicians editorial likewise describes proposed strategies of reducing the dose gradually or extending the interval between doses to limit rebound weight gain and sudden appetite increases.

Questions worth bringing to the appointment:

Should I taper, move to a lower dose, or space out my doses?
What should I weigh, measure and track, and how often?
How much protein do I need each day, and how do I protect muscle?
Are there labs worth checking, such as blood sugar markers, thyroid, sex hormones or nutrient levels?
What is our plan if my weight starts climbing or my appetite surges?

Medication decisions belong to the prescriber who knows your history. Do not change a dose or stop on your own, particularly if you also take medication for diabetes, where blood sugar needs monitoring.

The habits that protect your progress

The AAFP editorial lists maintenance strategies that are specific enough to act on: a protein-focused diet of about 1.05 g per kilogram of adjusted body weight, regular weigh-ins, food and exercise diaries, and 150 to 300 minutes of moderate-intensity exercise per week. Harvard Health adds protein- and fiber-rich meals, consistent eating times, a mix of aerobic and strength activity, good sleep and enough fluids.

Here is how that looks in practice.

Eat on a schedule, with protein first

Appetite can return quickly, so decisions made in the moment are harder. Plan three structured meals, build each around protein and fiber, and keep ready-to-eat options at home. For a 180 lb (82 kg) person, the 1.05 g/kg guideline works out to roughly 86 g of protein a day, though your own target should be set with a clinician or dietitian, especially if you have kidney disease.

Keep your muscle

Weight lost on treatment can include lean mass. Resistance training two to three days a week, plus walking or other aerobic work, helps preserve the muscle that keeps your resting metabolism up. Our own article on peptides for weight loss with muscle-preserving care covers why this matters during any weight-loss program.

Weigh in and write it down

A weekly weigh-in at the same time of day catches a trend early. A gain of a few pounds is a prompt to call your care team, not a failure. The earlier you adjust, the smaller the adjustment needs to be.

Protect sleep and manage stress

Short sleep and high stress both push appetite up. If your appetite is rebounding despite good habits, those are worth screening for along with other drivers. See our overview of the metabolic health reset for what tends to help and what does not.

Manage side effects that derail routines

Nausea, constipation and low appetite can make it hard to eat enough protein on treatment. Our clinician guide to GLP-1 side effects explains how to manage them so they do not undermine your nutrition before you ever reach the maintenance phase.

When a GLP-1 alone is not the whole plan

The pattern in the data is consistent: medication changes appetite, and habits, nutrition, movement and follow-up decide what happens when the effect changes. We make this case in A GLP-1 is a tool, not a plan. If you are comparing longer-term approaches, including surgical ones, this GLP-1 vs bariatric surgery comparison lays out how the options differ over time, and it can help you frame questions for your own physician.

Supervised care is also what keeps maintenance on track. Our overview of what medical weight loss involves explains how monitoring, labs and adjustments fit together.

Perspective

We see the same pattern in the clinic: people think of the end of a GLP-1 as a finish line, when it is really a hand-off. The medication carries the appetite side of the work for a while. What has to be ready by the time it stops is everything else: protein targets that are actually being met, a strength routine that has become normal, sleep that is protected, and labs that have been looked at together. That is why we start from root causes rather than the number on the scale. Thyroid function, sex hormones, blood sugar, gut health and nutrient status can all shape hunger and energy. When they are addressed alongside nutrition and movement, the stop or step-down becomes a planned transition and not a cliff. It also takes time. Our appointments are built to leave room for you to talk through your history, your fears about regaining and your real life, so that the plan fits you and not an average. Averages in the studies are useful. They are not your forecast. Dina

How Green Circle Wellness can support the transition

If you are on a GLP-1 and thinking about stopping, or you have already stopped and the scale is moving, our integrative team can help you build a plan that covers the whole picture. Medical weight loss care at Green Circle Wellness in Chicago is built around personalized testing and treatment plans, and nutritional consultations give you structured guidance on protein, meal timing and food choices. Where hormones or gut health may be part of the story, functional medicine looks at underlying causes. Virtual consults are available for Illinois residents.

You can see everything we offer on our services page, or learn how we work on the approach page.

FAQ

Is it easy to gain weight back after stopping a GLP-1?

For many people, yes. The BMJ meta-analysis found an average regain of about 0.4 kg per month after stopping weight-management medication. Regain is fastest in the first year and then tends to level off. A planned taper and strong habits can slow it.

How many GLP-1 users regain weight?

Most regain at least some. In the Epic Research analysis, complete regain at 24 months occurred in 21% to 27% of patients depending on the drug, while about 52% to 56% sustained some of their loss or lost more. The meta-regression estimates 60% of lost weight is regained by one year on average.

Does everyone regain weight after stopping semaglutide?

No. In the Epic Research data, 23% of semaglutide users had fully regained their weight at 24 months, and 56.1% had maintained their loss or lost more. Averages from trials are higher, with the STEP 1 extension showing about two-thirds of the loss regained after a year.

What percentage of people regain weight after stopping Mounjaro?

Mounjaro contains tirzepatide. In a 2026 systematic review, average regain after stopping tirzepatide was 13.04% of body weight, compared with 7.19% for semaglutide 2.4 mg. In the Epic Research analysis, 21% of tirzepatide users had regained all their weight at 24 months.

Can I prevent regain after a GLP-1?

You can reduce it. Ask your prescriber about tapering or a lower maintenance dose, eat enough protein, lift weights, get 150 to 300 minutes of moderate activity weekly, sleep well and keep tracking your weight. Keep follow-up appointments so changes are caught early.